Caplacizumab Treatment in a Case of Resistant Thrombotic Thrombocytopenic Purpura
preprint
OA: closed
Abstract
A 27-year-old G2P1 woman, admitted at 37 weeks of gestation after complaints of nausea, vomiting, and vaginal bleeding. An emergent vaginal delivery was performed which was complicated by significant blood loss. Thrombotic thrombocytopenic purpura was thought to be the most probable cause, requiring administration of caplacizumab and daily TPE.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.
Source provenance
- europepmc
- last seen: 2026-05-20T01:45:00.602351+00:00
- unpaywall
- last seen: 2026-06-04T02:00:05.705006+00:00